Skip to main content
Erschienen in: Osteoporosis International 1/2012

01.01.2012 | Original Article

Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies

verfasst von: Q. Wu, A. F. Bencaz, J. G. Hentz, M. D. Crowell

Erschienen in: Osteoporosis International | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Summary

Studies on use of selective serotonin reuptake inhibitors (SSRIs) and risk of fracture have yielded inconsistent results. This meta-analysis, which pooled results from 13 qualifying cohort and case–control studies, found that SSRIs were associated with a significantly increased risk of fractures.

Introduction

This study was conducted to assess whether people who take SSRIs are at an increased risk of fracture.

Methods

We conducted a meta-analysis of observational studies. Relevant studies published by February 2010 were identified through literature searches using MEDLINE (from 1966), EMBASE (from 1988), PsycINFO (from 1806), and manual searching of reference lists. Only cohort or case–control studies that examined the association of SSRIs and risk of fracture and bone loss were included. Data were abstracted independently by two investigators using a standardized protocol; disagreements were resolved by consensus. Random effects models were used for pooled analysis due to heterogeneity in the studies.

Results

Thirteen studies met inclusion criteria. Overall, SSRI use was associated with a significantly increased risk of fracture (relative risk, RR, 1.72; 95% CI [1.51, 1.95]; P < 0.001). An increased fracture risk associated with SSRIs also was observed in the three studies that adjusted for bone mineral density (RR, 1.70; 95% CI [1.28, 2.25]; P < 0.001) and in the four studies that adjusted for depression (RR 1.74; 95% CI [1.28, 2.36]; P < 0.001). SSRI use was not associated with bone loss in the two cohort studies of women (P = 0.29). The overall association between SSRI use and fracture risk was weaker (RR, 1.40; 95% CI [1.22, 1.61]), though still significant (P < 0.001) in analyses that accounted for apparent publication bias.

Conclusions

Use of SSRIs is associated with increased risk of fracture. The SSRIs may exert an increased risk of fracture independent of depression and bone mineral density.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Gehlbach SH, Avrunin JS, Puleo E (2007) Trends in hospital care for hip fractures. Osteoporos Int 18(5):585–591PubMedCrossRef Gehlbach SH, Avrunin JS, Puleo E (2007) Trends in hospital care for hip fractures. Osteoporos Int 18(5):585–591PubMedCrossRef
3.
Zurück zum Zitat Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991–2000): reversal of a secular trend. Bone 40(5):1284–1289PubMedCrossRef Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991–2000): reversal of a secular trend. Bone 40(5):1284–1289PubMedCrossRef
4.
Zurück zum Zitat Leslie WD, O'Donnell S, Jean S, Lagacé C, Walsh P, Bancej C, for the Osteoporosis Surveillance Expert Working Group et al (2009) Trends in hip fracture rates in Canada. JAMA 302(8):883–889PubMedCrossRef Leslie WD, O'Donnell S, Jean S, Lagacé C, Walsh P, Bancej C, for the Osteoporosis Surveillance Expert Working Group et al (2009) Trends in hip fracture rates in Canada. JAMA 302(8):883–889PubMedCrossRef
5.
Zurück zum Zitat Melton LJ III, Cooper C (2001) Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic, San Diego, pp 557–567CrossRef Melton LJ III, Cooper C (2001) Magnitude and impact of osteoporosis and fractures. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic, San Diego, pp 557–567CrossRef
6.
Zurück zum Zitat Pacher P, Ungvari Z (2001) Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses 57:469–471PubMedCrossRef Pacher P, Ungvari Z (2001) Selective serotonin-reuptake inhibitor antidepressants increase the risk of falls and hip fractures in elderly people by inhibiting cardiovascular ion channels. Med Hypotheses 57:469–471PubMedCrossRef
7.
Zurück zum Zitat Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303–1307PubMedCrossRef Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N (1998) Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303–1307PubMedCrossRef
8.
Zurück zum Zitat Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A et al (2003) Central nervous system active medications and risk for fractures in older women. Arch Intern Med 8:949–957CrossRef Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A et al (2003) Central nervous system active medications and risk for fractures in older women. Arch Intern Med 8:949–957CrossRef
9.
Zurück zum Zitat Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC et al (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188–194PubMedCrossRef Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC et al (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188–194PubMedCrossRef
10.
Zurück zum Zitat Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH (2008) Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 28:411–417PubMedCrossRef Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH (2008) Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 28:411–417PubMedCrossRef
11.
Zurück zum Zitat Lewis CE, Ewing SK, Taylor BC, Shikany JM, Fink HA, Ensrud KE et al (2007) Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res 22(2):211–219PubMedCrossRef Lewis CE, Ewing SK, Taylor BC, Shikany JM, Fink HA, Ensrud KE et al (2007) Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res 22(2):211–219PubMedCrossRef
12.
Zurück zum Zitat Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A (2003) Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158:77–84PubMedCrossRef Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A (2003) Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158:77–84PubMedCrossRef
13.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807–816PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807–816PubMedCrossRef
14.
Zurück zum Zitat Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD (2008) Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol 28:384–391PubMedCrossRef Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD (2008) Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol 28:384–391PubMedCrossRef
15.
Zurück zum Zitat van den Brand MW, Samson MM, Pouwels S, van Staa TP, Thio B, Cooper C et al (2009) Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 20:1705–1713PubMedCrossRef van den Brand MW, Samson MM, Pouwels S, van Staa TP, Thio B, Cooper C et al (2009) Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 20:1705–1713PubMedCrossRef
16.
Zurück zum Zitat French DD, Campbell R, Spehar A, Cunningham F, Foulis P (2005) Outpatient medications and hip fractures in the US: a national veterans study. Drugs Aging 22:877–885PubMedCrossRef French DD, Campbell R, Spehar A, Cunningham F, Foulis P (2005) Outpatient medications and hip fractures in the US: a national veterans study. Drugs Aging 22:877–885PubMedCrossRef
18.
Zurück zum Zitat Pirraglia PA, Stafford RS, Singer DE (2003) Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion J Clin Psychiatry 5:153–157PubMedCrossRef Pirraglia PA, Stafford RS, Singer DE (2003) Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion J Clin Psychiatry 5:153–157PubMedCrossRef
19.
Zurück zum Zitat Schneeweiss S, Wang PS (2004) Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 24(6):632–638PubMedCrossRef Schneeweiss S, Wang PS (2004) Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 24(6):632–638PubMedCrossRef
20.
Zurück zum Zitat Spangler L, Scholes D, Brunner RL, Robbins J, Reed SD, Newton KM et al (2008) Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 23(5):567–574PubMedCrossRef Spangler L, Scholes D, Brunner RL, Robbins J, Reed SD, Newton KM et al (2008) Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 23(5):567–574PubMedCrossRef
21.
Zurück zum Zitat Verdel BM, Surverein PC, Egberts TCG, van Staa VP, Leufkens HG, de Vries F (2010) Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone 47(3):604–609PubMedCrossRef Verdel BM, Surverein PC, Egberts TCG, van Staa VP, Leufkens HG, de Vries F (2010) Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures. Bone 47(3):604–609PubMedCrossRef
22.
Zurück zum Zitat Schwan S, Hallberg P (2009) SSRIs, bone mineral density, and risk of fractures—a review. Eur Neuropsychopharmacol 19:10683–10692CrossRef Schwan S, Hallberg P (2009) SSRIs, bone mineral density, and risk of fractures—a review. Eur Neuropsychopharmacol 19:10683–10692CrossRef
23.
24.
Zurück zum Zitat Ginzburg R, Rosero E (2009) Risk of fractures with selective serotonin reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 43:98–103PubMedCrossRef Ginzburg R, Rosero E (2009) Risk of fractures with selective serotonin reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 43:98–103PubMedCrossRef
25.
Zurück zum Zitat Bab I, Yirmiya R (2010) Depression, selective serotonin reuptake inhibitors, and osteoporosis. Curr Osteoporos Rep 8(4):185–191PubMedCrossRef Bab I, Yirmiya R (2010) Depression, selective serotonin reuptake inhibitors, and osteoporosis. Curr Osteoporos Rep 8(4):185–191PubMedCrossRef
26.
Zurück zum Zitat Haney EM, Bliziotes MM (2007) Selective serotonin reuptake inhibitors and bone health. Future Rheumatol 2(2):213–222CrossRef Haney EM, Bliziotes MM (2007) Selective serotonin reuptake inhibitors and bone health. Future Rheumatol 2(2):213–222CrossRef
27.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology—a proposal for reporting. JAMA 283:2008–2012PubMedCrossRef Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology—a proposal for reporting. JAMA 283:2008–2012PubMedCrossRef
28.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:W65–W94PubMed Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:W65–W94PubMed
29.
Zurück zum Zitat Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM et al (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167(12):1240–1245PubMedCrossRef Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM et al (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167(12):1240–1245PubMedCrossRef
30.
Zurück zum Zitat Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ (2002) Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 288:728–737PubMedCrossRef Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ (2002) Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA 288:728–737PubMedCrossRef
31.
Zurück zum Zitat Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Meth Med Res 8:135–160CrossRef Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Meth Med Res 8:135–160CrossRef
32.
Zurück zum Zitat Etminan M, Takkouche B, Isorna FC, Samii A (2005) Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 330:63PubMedCrossRef Etminan M, Takkouche B, Isorna FC, Samii A (2005) Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 330:63PubMedCrossRef
33.
Zurück zum Zitat Walter SD, Cook RJ (1991) A comparison of several point estimators of the odds ratio in a single 2 × 2 contingency table. Biometrics 47(3):795–811PubMedCrossRef Walter SD, Cook RJ (1991) A comparison of several point estimators of the odds ratio in a single 2 × 2 contingency table. Biometrics 47(3):795–811PubMedCrossRef
34.
Zurück zum Zitat Kahn HA, Sempos CT (1989) Statistical methods in epidemiology. Monogr epidemiol biostat 12:292 Kahn HA, Sempos CT (1989) Statistical methods in epidemiology. Monogr epidemiol biostat 12:292
35.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef
36.
Zurück zum Zitat Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560PubMedCrossRef
37.
Zurück zum Zitat Furukawa TA, Guyatt GH, Griffith LE (2002) Can we individualize the ‘number needed to treat’? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol 31(1):72–76PubMedCrossRef Furukawa TA, Guyatt GH, Griffith LE (2002) Can we individualize the ‘number needed to treat’? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol 31(1):72–76PubMedCrossRef
38.
Zurück zum Zitat Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53:1119–1129PubMedCrossRef Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53:1119–1129PubMedCrossRef
39.
Zurück zum Zitat Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRef Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101PubMedCrossRef
40.
Zurück zum Zitat Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463PubMedCrossRef Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455–463PubMedCrossRef
41.
Zurück zum Zitat Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339:875–882PubMedCrossRef Thapa PB, Gideon P, Cost TW, Milam AB, Ray WA (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339:875–882PubMedCrossRef
42.
Zurück zum Zitat Arfken CL, Wilson JG, Aronson SM (2001) Retrospective review of selective serotonin reuptake inhibitors and falling in older nursing home residents. Int Psychogeriatr 13(1):85–91PubMedCrossRef Arfken CL, Wilson JG, Aronson SM (2001) Retrospective review of selective serotonin reuptake inhibitors and falling in older nursing home residents. Int Psychogeriatr 13(1):85–91PubMedCrossRef
43.
Zurück zum Zitat Darowski A, Chambers S, Chambers D (2009) Antidepressants and falls in the elderly. Drugs Aging 26(5):381–394PubMedCrossRef Darowski A, Chambers S, Chambers D (2009) Antidepressants and falls in the elderly. Drugs Aging 26(5):381–394PubMedCrossRef
44.
Zurück zum Zitat Wu Q, Liu J, Gallegos-Orozco J, Hentz JG (2010) Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 21(10):1627–1635PubMedCrossRef Wu Q, Liu J, Gallegos-Orozco J, Hentz JG (2010) Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 21(10):1627–1635PubMedCrossRef
45.
Zurück zum Zitat Wu Q, Magnus JH, Liu J, Bencaz AF, Hentz JG (2009) Depression and bone mineral density: meta-analysis of epidemiological studies. Osteoporos Int 20(8):1309–1320PubMedCrossRef Wu Q, Magnus JH, Liu J, Bencaz AF, Hentz JG (2009) Depression and bone mineral density: meta-analysis of epidemiological studies. Osteoporos Int 20(8):1309–1320PubMedCrossRef
46.
Zurück zum Zitat Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118(12):1414PubMedCrossRef Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118(12):1414PubMedCrossRef
47.
Zurück zum Zitat Romas E (2005) Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates. Best Pract Res Clin Rheumatol 19(6):1065–1079PubMedCrossRef Romas E (2005) Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates. Best Pract Res Clin Rheumatol 19(6):1065–1079PubMedCrossRef
48.
Zurück zum Zitat Harpavat M, Keljo DJ, Regueiro MD (2004) Metabolic bone disease in inflammatory bowel disease. J Clin Gastroenterol 38(3):218–224PubMedCrossRef Harpavat M, Keljo DJ, Regueiro MD (2004) Metabolic bone disease in inflammatory bowel disease. J Clin Gastroenterol 38(3):218–224PubMedCrossRef
Metadaten
Titel
Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies
verfasst von
Q. Wu
A. F. Bencaz
J. G. Hentz
M. D. Crowell
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 1/2012
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-011-1778-8

Weitere Artikel der Ausgabe 1/2012

Osteoporosis International 1/2012 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.